Number of approved ANDAs in U.S. 2009-2017
Number of approved abbreviated new drug applications (ANDAs) in the U.S. from 2009 to 2017
This statistic depicts the number of approved abbreviated new drug applications (ANDAs) in the U.S. from 2009 to 2017. In 2017, around 767 ANDAs were approved compared to 489 ANDAs approved in the year 2009.
Number of approved abbreviated new drug applications (ANDAs) in the U.S. from 2009 to 2017
Source
More information
Statistics on "Pharmaceutical trends in Europe"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Average number of ANDAs received per month in U.S. 2009-2017
- Average number of approved ANDAs per month in U.S. 2009-2017
- Number of ANDA approvals in U.S. 2015-2017, by type
- Number of ANDAs received in U.S. 2009-2017
- U.S. spending on specialty medicine by type 2012-2016
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Share of drug dispensing costs in select public drug plans Canada 2011-2017
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Zolpidem and drug combinations leading to ED visits in the U.S. 2010
- Top specialty drug pharmacies in the U.S. by revenue 2018
- Canadian drug market sales contribution of patented drugs 1990-2017
- Number of pharmaceuticals on China's national reimbursement drug list
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- Public drug program spending in Canada by top drug classes 2017
- Industry turnover for leading pharmaceuticals German 2017
- Average price ratio of patented drugs in Canada 2017 and year of introduction
- Patented drug products annual sales in Canada 1990-2017
Statistics on "Pharmaceutical trends in Europe"
Related topics
About Statista
